Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.
复制标题
DOI:
10.1016/j.molonc.2009.02.004
复制
发表时间:
2009-04
影响因子:
6.6
通讯作者:
Godwin AK
中科院分区:
文献类型:
--
作者:
Lynch HT;Casey MJ;Snyder CL;Bewtra C;Lynch JF;Butts M;Godwin AK
Hereditary ovarian cancer accounts for at least 5% of the estimated 22,000 new cases of this disease during 2009. During this same time, over 15,000 will die from malignancy ascribed to ovarian origin. The bulk of these hereditary cases fit the hereditary breast-ovarian cancer syndrome, while virtually all of the remainder will be consonant with the Lynch syndrome, disorders which are autosomal dominantly inherited. Advances in molecular genetics have led to the identification of BRCA1 and BRCA2 gene mutations which predispose to the hereditary breast-ovarian cancer syndrome, and mutations in mismatch repair genes, the most common of which are MSH2 and MLH1, which predispose to Lynch syndrome. These discoveries enable relative certainty limited only by their variable penetrance, so that early diagnosis through a comprehensive cancer family history might be possible. This paper reviews the subject of hereditary ovarian cancer, with particular attention given to its molecular genetic basis, its pathology, and its phenotypic/genotypic heterogeneity.
登录
查看更多内容
影响因子:
120.7
作者:
Boyd, J;Sonoda, Y;Hoskins, WJ
通讯作者:
Hoskins, WJ
影响因子:
5.6
作者:
Agoff, SN;Mendelin, JE;Garcia, RL
通讯作者:
Garcia, RL
DOI:
10.1093/jnci/91.19.1654
发表时间:
1999-10-06
期刊:
JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子:
--
作者:
Bernstein, L;Deapen, D;Ford, L
通讯作者:
Ford, L
影响因子:
168.9
作者:
Bergman, L;Beelen, MLR;van Leeuwen, FE
通讯作者:
van Leeuwen, FE
DOI:
10.1097/00004347-199207000-00003
发表时间:
1992-07-01
影响因子:
2.4
作者:
BEWTRA, C;WATSON, P;LYNCH, HT
通讯作者:
LYNCH, HT